Matthew Angel - President and CEO, Director at Ernexa Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
ERNA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Angel since 01 Feb 2025

Holdings reported by Matthew Angel for Ernexa Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 132,003 12 Jan 2023 Direct Common Stock, par value $0.005 per share

Transactions reported by Matthew Angel for Ernexa Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.